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Abstract
Angiogenesis is a complex process orchestrated by both growth factors and cell adhesion and is initiated by focal
degradation of the vascular basement membrane with subsequent migration and proliferation of endothelial cells. The Ras/
Raf/MEK/ERK pathway is required for EC function during angiogenesis. Although in vitro studies implicate ERK1 and ERK2 in
endothelial cell survival, their precise role in angiogenesis in vivo remains poorly defined. Cre/loxP technology was used to
inactivate Erk1 and Erk2 in endothelial cells during murine development, resulting in embryonic lethality due to severely
reduced angiogenesis. Deletion of Erk1 and Erk2 in primary endothelial cells resulted in decreased cell proliferation and
migration, but not in increased apoptosis. Expression of key cell cycle regulators was diminished in the double knockout
cells, and decreased DNA synthesis could be observed in endothelial cells during embryogenesis. Interestingly, both Paxillin
and Focal Adhesion Kinase were expressed at lower levels in endothelial cells lacking Erk1 and Erk2 both in vivo and in vitro,
leading to defects in the organization of the cytoskeleton and in cell motility. The regulation of Paxillin and Focal Adhesion
Kinase expression occurred post-transcriptionally. These results demonstrate that ERK1 and ERK2 coordinate endothelial cell
proliferation and migration during angiogenesis.
Citation: Srinivasan R, Zabuawala T, Huang H, Zhang J, Gulati P, et al. (2009) Erk1 and Erk2 Regulate Endothelial Cell Proliferation and Migration during Mouse
Embryonic Angiogenesis. PLoS ONE 4(12): e8283. doi:10.1371/journal.pone.0008283
Editor: Robert Alan Arkowitz, CNRS UMR6543 - Universite ´ de Nice - Sophia Antipolis, France
Received September 20, 2009; Accepted November 19, 2009; Published December 14, 2009
Copyright:  2009 Srinivasan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: NCI grants R01-CA53271, P01-CA097189 and the Evelyn Simmers Foundation (MCO). TZ was funded by a predoctoral fellowship from the Department
of Defense Breast Cancer Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: michael.ostrowski@osumc.edu
Introduction
Angiogenesis is a multi-step process involving a concerted
remodeling of the primitive vascular plexus to a mature functional
vascular network [1]. It is a fundamental process in normal growth
and development. It is also an essential element in processes such as
wound healing and inflammation, and in many pathological
conditions, such as cancer. Soluble factors including vascular
endothelial growth factor (VEGF) play key roles in this initial
process, but cell adhesion/extracellular matrix interactions are also
critical determinants of endothelial cell (EC) migration and
proliferation [2].
Of the array of signaling events activated in response to VEGF and
cell adhesion, the Ras/Raf/MEK/ERK1/2 pathway is known to play
a prominent role in EC function [3,4,5,6,7]. Targeted deletion of genes
in the Ras pathway, for example, B-Raf, MEK1 and Ras-GAP,l e a d st o
vascular defects during embryogenesis [8,9,10,11]. However, Erk1
2/2
mice are viable with no angiogenic phenotypes [12,13] and Erk2
2/2
mice are embryonic lethal before vascularization and angiogenesis
occur [14,15,16]. A large body of work demonstrates that the mitogen
activated protein kinases ERK1 and ERK2 (ERK1/2) are critical for
angiogenesis: however, the data is largely based on cell culture studies
using dominant negative genes, siRNA and small molecule inhibitors
to antagonize the kinases that lie upstream of ERK in the signaling
pathway [17,18,19,20,21,22]. These in vitro studies implicate the Ras/
Raf pathway, and by extension ERK1/2, in EC survival and motility
[17,18,19,20,21,22]. However, besides Erk, many other signaling
cascades such as src, FAK, PI3K/Akt, p38MAPK and JNK function
downstream of growth factor and cell adhesion receptors, and many of
these pathways have been implicated in the same biological processes
[23,24,25,26,27,28,29,30].
In order to better understand how ERK1 and ERK2 regulate
angiogenesis, we used a genetic approach using Cre/loxP
technology to conditionally delete Erk2 in Erk1-null mice using
the EC specific Tie2-Cre [31]. Embryos lacking Erk1/2 in EC died
in utero at E10.5 due to reduced angiogenesis both in the yolk sac
and embryo proper. Gene expression profiling of isolated aortic
EC identified cell cycle and cell migration as the principal
biological processes affected in the double mutant EC. Consistent
with the microarray profiling, EC lacking ERK1/2 show highly
reduced proliferation and migration both in vivo and in vitro. The
mechanism by which ERK1/2 regulated cell proliferation
involved transcriptional regulation of genes necessary for cell
cycle, including CyclinA, CyclinB, CyclinD1, CyclinE and c-Myc.
Additionally ERK1/2 regulated the abundance of proteins like
Paxillin and Focal Adhesion Kinase that are required for cell
PLoS ONE | www.plosone.org 1 December 2009 | Volume 4 | Issue 12 | e8283migration. These results reveal a redundant role for Erk1 and Erk2
in coordinating EC proliferation and migration, two processes
necessary for embryonic angiogenesis.
Materials and Methods
Mice
Erk1-null and Erk2
fl mice were described previously [12,32]. The
Erk2
fl mice harbor loxP sites flanking exon 2. Cre-mediated
recombination of this site results in the generation of the Erk2-null
or Erk2-KO allele. Tie2-Cre mice were described previously [31].
All animals were maintained on pure C57/BL6 background (5
generations). Mice were genotyped by PCR. Primers and
conditions used are available upon request. Use and care of mice
in this study were approved by the Ohio State University
Institutional Animal Care and Use Committee.
Isolation of endothelial cells
Mouse aortic and lung EC were isolated from Erk1
2/2;Erk2fl
/fl
and Erk1
+/2;Erk2
fl/f mice as previously described [33,34]. Aortic
and lung EC populations were labeled with 5 mg/mL Di-I-
acetylated low-density lipoprotein (Di-I-Ac-LDL, Upstate) and
enriched by fluorescent activated cell sorting as the final step of
purification. The purified EC populations were characterized and
maintained in complete EC medium (Dulbecco modifies Eagle
medium (DMEM)-F12 with 20% heat inactivated FBS plus
penicillin-streptomycin, 30 mg/ml endothelial cell growth supple-
ment (Upstate Biotechnology) and 10 U/ml heparin (Sigma-
Aldrich)) in 37uC incubator at 5% CO2.
Lentiviral Transduction
Duplicate cultures of Erk1
2/2;Erk2fl
/fl and Erk1
+/2;Erk2
fl/f EC
(5610
5 cells) were cultured overnight and infected with ecotropic
lentivirus with and without PGK-Cre, to generate control and
double mutant (DKO) EC, respectively (pHAGE-IRES-GFP
vectors used were a gift from Dr.N.Danial’s laboratory at Harvard
University). Infections of the duplicate cultures were performed as
described previously [35]. The infected cells were harvested 72 hrs
post-infection, when the endogenous pool of ERK2 present before
infection was sufficiently depleted and morphological differences
between control and DKO cells are first noted. All subsequent
experiments were performed on the duplicate cultures, one
infected with Cre and one without, beginning at 72 hrs post-
infection.
Quantitative real-time PCR
Total RNA was extracted from aortic and lung EC 72 hrs post
viral infection by TRIzol (Invitrogen) according to the manufac-
turers’ instructions. Samples were analyzed by q-PCR as
previously described [35]. Students t-test was used to determine
the statistical significance of the expression differences between the
DKO and control genotypes.
Microarray Analysis
A detailed description of microarray analysis is presented in
Table S3. Briefly, cells used for this study were generated from
three independent pairs of aortic EC infected with lentiviral-eGFP
with and without Cre. RNA was extracted from control and DKO
EC at 72 hrs post-lentivirus infection. Microarray was performed
with these RNA samples on Affymetrix Mouse Exon v1.0 ST
Array GPL6193 platform. RMA method was applied to the
primary data to correct the technical bias and summarize gene
expression values over probe-sets [36]. The gene expression
differences were then compared between EC with or without
ERK1/2. The gene list was filtered based on the fold change in
expression between the two genotypes. Targets showing .4-fold
significant (p,0.05) change in expression in the DKO compared
to control EC were subjected to DAVID Annotation Analysis
(http://david.abcc.ncifcrf.gov/).
Histology and Immunostaining
Whole-mount CD31 staining on embryos was performed as
previously described [37]. Embryos were fixed in 4% paraformal-
dehyde (PFA) overnight, paraffin or OCT embedded and 5 mm
sections were prepared. Immunostaining was performed as
previously described [35,38]. Primary antibodies used were rat
anti- CD31 (MEC13.3, BD Phamingen), rabbit anti-ERK1/2
(Santa Cruz), rabbit anti-cleaved Caspase-3 (Cell Signaling),
mouse anti-BrDU (DAKO Cytomation), rabbit anti-Paxillin
(Abcam), rabbit anti-FAK (Cell Signaling) and rabbit anti-
pY397-FAK (Abcam). Biotinylated secondary antibodies used
were from BD Biosciences. The antibody staining was imaged
using an Axioscope 40 microscope (Zeiss) equipped with an
Axiocam HRc camera (Zeiss). Immunostaining was quantified in
embryonic blood vessels in the head, lining the heart, the dorsal
aorta, the cardinal vein, and the intersomatic vessels. At least 10
vessels (,400 EC) were counted per embryo in each group and
were quantified using Metamorph 6.0. For non-EC, Metamorph
6.0 was used to count and quantify staining in all embryonic cell
types (such as smooth muscle cells, epithelial cells, cardiomyo-
cytes), especially cells adjacent to blood vessels. Approximately
1500 non-EC cells per embryo in each genetic group were counted
and scored.
EC plated on Fibronectin (FN)-coated dishes (10 mg/ml) were
used for double immunofluorescence assays. Alexa-594 conjugated
donkey anti-mouse (Invitrogen), Alexa-488/594 conjugated sec-
ondary antibodies (Invitrogen) were used for immunofluorescence
analysis. Images of stained EC were acquired using a Zeiss 510
META laser scanning confocal microscope. For the Erk1
2/2;
Erk2
2/2 DKO cells, which express low levels of GFP through an
IRES sequence, the FITC intensity of unstained DKO ECs was
set as background. Using this as the basal level, FITC expression in
Paxillin immunostained DKO EC was evaluated. Results
presented have the GFP background signal filtered. To confirm
the results, in separate single label experiments Paxillin was stained
using the Alexa598 red conjugate (data not shown). Phalloidin
labeling was performed on EC according to the manufacturers’
instructions (Invitrogen). Immunostaining of EC in culture was
performed 72 hrs post viral infection.
Western Blotting
Total protein was extracted from at least two control and DKO
EC 72 hours post viral infection and western blot was performed
as previously described [35]. Primary antibodies raised in rabbit
against ERK1/2, CyclinD1, CyclinA, CyclinE, CyclinB1, CDK4
and CDK1, and mouse anti-c-Myc were purchased from Santa
Cruz Biotechnology. Other primary antibodies used were rabbit
anti-Paxillin (Abcam), rabbit pS473-AKT and rabbit anti-FAK
(Cell Signaling) and rabbit anti-pY397-FAK (Abcam).
Cell Proliferation and Migration assays
72 hrs post viral infection, 3610
5 EC were plated overnight
with fresh media and subsequently incubated with 3 mg/ml BrDU
(Sigma) for 2 hrs in 37uC incubator at 5%CO2. The cells were
then fixed and BrDU staining was performed as previously
described [38]. For all migration assays, EC obtained 72 hrs post
viral infection were used. For Scratch Wound Assay, EC were
cultured an additional 24 hrs until confluent, incubated with
Erk Function in Angiogenesis
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surface with a 10-ml standard pipette tip. The wounded
monolayers were then imaged over 24 hrs under the Live Imaging
Zeiss microscope. Cell migration was calculated as the number of
EC migrating into the wound area at various time points
indicated. Single cell migration track assays were performed as
previously described and quantified using Metamorph 6.0 [39].
The vessel-forming ability of EC was characterized in vitro using a
Matrigel assay. Briefly, 4610
4 EC were sandwiched between two
layers of Matrigel (BD Biosciences, 10 mg/ml) and cultured in
complete EC media. Tube formation was monitored over a period
of a week.
EC apoptosis and senescence assays
Serum starvation (0.1% serum for 24 hrs) was used to induce
apoptosis in EC infected with lentivirus with and without Cre
(72 hrs post infection). Apoptosis was assayed using fluorescence
labeled LIVE/DEAD Cell Viability Kit (Invitrogen) according to
the manufacturer’s protocol and quantified using Metamorph6.0
as previous described [35]. Senescence assays were performed as
previously described [40].
Statistical Analysis
General Linear Models were used to analyze staining
differences in immunostaining experiments. MINITAB was used
for the analyses.
Results
Ablation of Erk1 and Erk2 in EC results in embryonic
lethality and defective angiogenesis
In order to study the potential overlapping roles of Erk1/2 in the
development of the vascular system, a genetic approach employing
Cre/LoxP technology was used to generate mice with both genes
absent in EC. For this purpose we generated mice homozygous for
a conditional Erk2 allele, Erk2
fl (with exon 2 flanked by loxP sites)
[32], homozygous for the conventional knockout allele of Erk1
[12], and containing the well-characterized Tie2-Cre transgene to
effect recombination of Erk2
fl in EC [31]. Mice with genotype
Erk1
2/2;Erk2
fl/fl;Tie2-Cre (EC-DKO mice) were expected to be
born at a frequency of 12.5% from the initial breeding scheme
employed (see Figure S1A for breeding schemes). However, no
mutant EC-DKO mice were born, suggesting embryonic lethality;
other expected genotypes were found at the predicted ratios,
indicating that one copy of either Erk1 or Erk2 in EC was sufficient
for embryonic development (Table S1).
To determine when lethality occurred, embryos obtained from
timed matings were studied, demonstrating that EC-DKO
embryos were alive at E9.5, when the Tie2-Cre transgene utilized
in these studies becomes active in the embryo body [31], but no
longer viable at E10.5 (Figure 1A; Tables S1 and S2). The viable
EC-DKO E9.5 embryos were smaller than the control littermates
(Figure 1A). There was no significant difference in the number of
somites present in the mutant mice compared to the controls
(Figure S1B). Blood vessels were not visible in the yolk sac of the
EC-DKO embryos at E9.5, consistent with the timing of
expression of Tie2-Cre in yolk sac beginning at E7.5-8.5 [31]
(Figure S1D). Furthermore, EC-DKO mutant hearts were much
smaller with highly reduced cellularity and the endocardial layer
was detached from myocardial trabeculae suggesting defective
heart development and function (Figure S1E).
In order to verify that both Erk1/2 were selectively deleted in
EC, immunohistochemistry was performed on sections from viable
E9.5 embryos using a pan-ERK1/2 antibody. While robust
ERK1/2 expression was detected in EC present in controls, a
selective 8-fold reduction of ERK1/2 expression was observed in
EC in the EC-DKO mutants (Figure 1B). Notably, there was no
significant difference in ERK1/2 expression in other embryonic
non-EC types such as smooth muscle cells, epithelial cells,
cardiomyocytes etc. (Figure S1C).
Whole mount CD31 staining was employed to determine the
extent of angiogenic remodeling in the EC-DKO embryos, an
analysis that revealed a striking reduction in vascular complexity in
the EC-DKO embryos examined (n=7) compared to controls
(n=10) at this stage (Figure 1C and Figure S1F). While the control
littermates underwent extensive blood vessel branching and
maturation at E9.5, the EC-DKO embryos had only large
unbranched vessels, especially evident in the heart, head and
trunk regions. Additionally, whole mount CD31 staining of EC-
DKO yolk sacs (n=4) revealed large vessels and decreased
vascular density compared to the control littermates (n=4),
confirming that angiogenesis was impaired in this embryonic tissue
(Figure S1D).
Gene expression profiling of ERK1/2 deficient EC
identified proliferation and migration as affected
biological processes
To directly address the mechanisms that might be contributing to
the lethality in the double mutant embryos, primary aortic EC and
microvascular lung EC were isolated and cultured from Erk1
2/2;
Erk2
fl/fl mice. The EC identity and relative purity of the cultured
cells was confirmed by the uptake of fluorescent-labeled low density
lipoprotein and CD31 staining (Figure S2A and S2B). The purified
cell populations were infected with lentivirus expressing both Cre
and eGfp to generate aortic EC lacking Erk1 and Erk2 (DKO EC).
The efficiency of lentiviral-Cre mediated recombination was
analyzed by Western analysis and indirect immunofluorescence,
demonstrating a 10-fold reduction in ERK2 protein levels
(Figure 2A and Figure S2C, respectively). Similar results were
obtained with the lung microvascular cells (Figure S2D). Aortic and
lung EC of genotype Erk1
2/2;Erk2
fl/fl infected with lentivirus
without Cre were used as controls for subsequent experiments.
Subsequently, total RNA was isolated from DKO and control
EC and subjected to gene expression profiling using the Affymetrix
platform. The expression profiling was performed on three
independent pairs of aortic EC cultures. RNA was isolated from
DKO EC 72 hrs post lentiviral expression, sufficient time for
endogenous ERK proteins to turn over. Analysis of the microarray
data yielded 281 genes that showed 4-fold or greater, statistically
significant changes in gene expression (Table S4). Of these, 144
genes were downregulated and 137 genes were upregulated. Gene
ontology identified four principal biological processes affected by
the loss of Erk1/2 in EC: cell cycle/proliferation, cell migration/
angiogenesis, transcriptional regulation and inflammatory re-
sponse (Figure 2B).
To verify the microarray results, quantitative real-time RT-
PCR (q-PCR) was performed on RNA prepared from an
independently derived set of aortic EC. 35 genes with greater
than four-fold differential expression that represented the major
biological processes affected were selected for verification. In
addition, we selected for q-PCR verification another 13 genes
described in the literature to be regulated by ERK signaling (e.g.
MMP9 and uPA), that were differentially expressed greater than
two-fold in the microarray analysis (Table S5). All 48 genes tested
by q-PCR were found to be significantly differentially expressed in
DKO versus control aortic EC (Figure 2C-D; Figure S2E). EC-
specific genes (Cd31 and Flt1), EC-growth factor (Vegf-c), cell cycle
regulators (p27 and p53), and pro-apoptotic genes (Caspase3) were
Erk Function in Angiogenesis
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2/2;Erk2
fl/fl;Tie2-Cre mutant embryos. (A) E10.5 day (top) and E9.5
(bottom) embryos; control embryo is at the left, DKO at the right. Bars=0.5 mm. (B) Consecutive paraffin sections of control (left) and Erk1
2/2;Erk2
fl/fl;
Tie2-Cre (EC-DKO) (right) embryos were stained with anti-ERK1/2 (top) and anti-CD31 (bottom) antibodies. Representative data for E9.5 embryo are
shown; a total of 4 embryos were analyzed. Red dotted lines mark the outer lining of the EC layer and arrowheads point to representative EC.
Bars=20 mm. The graphic panel indicates the ratio of ERK positive EC to total CD31-positive cells, expressed as percent positive EC. (C) E9.5 embryos
analyzed by whole mount staining with anti-CD31 antibody. Controls are in the top row and EC-DKO mutants in the bottom row. Arrowheads
highlight examples of blood vessel staining and branching in the controls that are reduced in the EC-DKO embryos. Bars=0.5 mm.
doi:10.1371/journal.pone.0008283.g001
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of many of the genes differentially regulated in DKO aortic EC
was studied in the microvascular lung EC, revealing differential
expression in this distinct type of EC as well (Figure S2G).
Erk1 and Erk2 regulate EC proliferation in vivo and in vitro
Since the expression profiling results predicted differences in cell
proliferation and migration, these processes were selected for further
analysis. EC proliferation in EC-DKO embryos was analyzed by
employing a BrDU incorporation assay (Figure 3A). EC-DKO
mutant embryos showed a selective 3-fold decrease in BrDU
incorporation in EC compared to controls (Figure 3A). Importantly,
there was no significant difference in BrDU incorporation in other
non-EC types such as smooth muscle cells, epithelial cells,
cardiomyocytes (Figure S3A). Because previous studies had implicat-
ed ERK1/2 in EC survival during angiogenesis, cleaved Caspase-3
immunostaining was used to determine if EC apoptosis was affected
in EC-DKO embryos. The results demonstrated that apoptosis was
low in EC in E9.5 embryos, with no significant difference between
EC-DKO and control embryos (Figure 3B).
Consistent with the in vivo data, there was a 4.5-fold reduction in
BrDU incorporation in DKO compared to control aortic EC in vitro
Figure 2. Loss of ERK1/2 in EC affects Cell cycle/proliferation and Cell migration/angiogenesis. (A) Protein expression of ERK1/2 in
lentivirus infected aortic control and DKO EC by Western analysis. Erk1
+/2;Erk2
fl/fl (lane 1) and Erk1
2/2;Erk2
flfl without (lane 2) and with (lane 3) Cre. (B)
Principal biological processes affected by the loss of ERK1/2 in aortic EC. Indicated is the % genes differentially expressed in DKO EC. (C and D) Gene
expression analysis of cell cycle/proliferation (C) and cell migration/ECM remodeling/angiogenesis (D) regulators by q-PCR in cultured aortic EC with
and without ERK1/2, n=3.
doi:10.1371/journal.pone.0008283.g002
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incorporationcompared towild-type controls(FigureS3B). Further,
aortic EC with only one Erk allele do not show significant difference
in BrDU incorporation compared to the controls (Figure S3C). This
suggested that one copy of either Erk gene was sufficient to maintain
normal EC proliferation. Additionally, consistent with in vivo results,
there was no difference in apoptosis in DKO versus control aortic
EC when stressed by serum deprivation (Figure S3D).
Western blotting was used to analyze the expression of several cell
cycle regulators in aortic EC. A marked diminution of proteins
regulating G1 to S phase progression was observed, including
CyclinD1, CyclinE, CDK4 and c-Myc in the DKO aortic EC
(Figure 3D). Interestingly, the expression of G2-M regulators such as
CyclinA, CyclinB1 and CDK1 were also lower in DKO aortic EC
(Figure 3D).
Deletion of Erk1/2 in either aortic or lung EC in vitro led to
marked morphological changes, including larger and flattened cells.
To test whether cell senescence was being triggered by deletion of
the Erk genes, we stained cells for SA-bgal activity, a biomarker of
cellular senescence (Figure S3E). Neither DKO nor control aortic
EC expressed SA-bgal under normal culture conditions; however,
upon the induction of senescence by UV-irradiation, both DKO
andcontrolaorticECstainedforSA-bgal(FigureS3E).Thus,lossof
ERK1/2 did not directly trigger cell senescence in cultured EC.
Erk1/2 ablation in EC results in reduced EC migration and
tube formation in vitro
Three different assays that measure cell motility and invasive-
ness were used to examine the effect of Erk1/2 deletion on cell
Figure 3. Reduced cell proliferation in ERK1/2 deficient EC. (A) Representative paraffin sections from E9.5 control (left, n=4) and EC-DKO
(right, n=4) embryo sections stained for anti-BrDU. The red dotted lines indicate the outer lining of the EC layer and the arrowheads point to
representative EC. The bar graph represents the fraction of BrDU positive to total EC. Bars=20 mm. (B) Anti-cleaved Caspase-3 staining of
representative paraffin sections from E9.5 control (left, n=4) and EC-DKO (right, n=4) embryo. The red dotted lines indicate the outer lining of the EC
layer. The graphic panel indicates the fraction of EC staining for cleaved Caspase-3 to total EC. Bars=20 mm. (C) Anti-BrDU staining on cultured aortic
EC of the indicated genotype, without (top panel) and with (bottom panel) Cre. Red-BrDU and Blue-DaPI. The graph indicates the ratio of BrDU
positive to total EC with 3 independent experiments represented. Bars=20 mm. (D) Western blot analysis on lysates from Erk1
+/2;Erk2
fl/fl-Cre (lane 1),
Erk1
2/2;Erk2
fl/fl-Cre (lane 2) and Erk1
2/2;Erk2
fl/fl+Cre for the antibodies indicated.
doi:10.1371/journal.pone.0008283.g003
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performed. After wounding (and in the presence of MitomycinC),
control EC efficiently migrated into the wounded area within
24 hrs (Figure 4A). In contrast, the DKO aortic EC failed to
migrate into the wounded area (Figure 4A, Movies S1 and S2).
Similar results were also observed with DKO lung EC (Figure
S4A). Further, aortic EC with only one Erk allele did not show
significant differences in motility in this assay (Figure S4B). As
above, this result suggested that one copy of either Erk gene was
sufficient for normal EC migration. The results of the scratch
assays from DKO and control EC were confirmed using a single
cell migration track assay in which migrating cells engulf
fluorescent beads leaving a non-fluorescent track (Figure S4C). A
6-fold decrease in motility of the DKO aortic EC compared to
control was measured in this assay. Cell invasiveness of DKO EC
was examined in a Matrigel ‘‘sandwich’’ assay with EC placed
between two layers of Matrigel. The DKO aortic EC failed to
invade into the Matrigel and to form tube-like structures as
observed for controls (Figure 4B).
Erk1/2 deletion altered expression and localization of
Paxillin and FAK
Previous studies in EC have shown that ERK1/2 regulate the
organization of the actin cytoskeleton and hence cell motility
[19,41,42,43]. Consistent with these studies, phalloidin stained
DKO compared to control aortic EC demonstrated a dramatic
loss of actin cytoskeletal organization, in particular the loss of
intracellular stress fibers and marked peripheral accumulation of
actin in both aortic and lung DKO EC compared to controls
(Figure 5A and Figure S5A).
Paxillin and Focal Adhesion Kinase (FAK) are two factors
indispensable for actin filament assembly, cell spreading and cell
migration [44]. Indirect immunofluorescence was used to assess
whether Paxillin and FAK localization were affected in DKO EC
plated on fibronectin (FN) coated dishes. While the control EC
demonstrated expression and co-localization of Paxillin and
pY397-FAK at the membrane and within focal adhesions, staining
was greatly diminished in DKO aortic EC and focal adhesions
were not detected with these markers (Figure 5B). Consistent with
the double immunofluorescence analysis, the expression of Paxillin
and FAK (both total and pY397-FAK), were significantly reduced
in DKO compared to control aortic EC as demonstrated by
Western blotting (Figure 5C). The mRNA levels for both Paxillin
and Fak, were unchanged in DKO EC compared to controls
indicating that the changes in protein expression were due to post-
transcriptional events (Figure S5B). The Paxillin/FAK complex
activates the PI-3 Kinase pathway and AKT [45]. However, no
difference in activated pS473-AKT was observed in the DKO
aortic EC (Figure S5C).
To determine whether Paxillin and FAK were affected in EC-
DKO embryos, immunohistochemistry was used to analyze their
expression in E9.5 embryos. Importantly, EC-DKO embryos
showed an 8-fold reduction in EC-specific staining for Paxillin and
a 4-fold decrease in FAK staining (Figure 6A and 6B, respectively).
There was no significant difference in Paxillin and FAK staining in
the other embryonic non-EC types such as smooth muscle cells,
epithelial cells, cardiomyocytes etc. (Figure S5D).
Figure 4. EC lacking ERK1/2 display reduced migration and invasion potential in vitro. (A) Confluent monolayer of control (top panel) and
DKO (bottom panel) aortic EC were wounded and wound closure was monitored over 24 hrs. Representative results from t=0 h (left panel) and
t=24 h (right panel) are shown (n=3). The graph indicates the quantification of the number of cells migrating into the wound over the indicated
time points. Bars=40 mm. (B) In vitro matrigel sandwich assay showing invasion and tube-like formation by control aortic EC (top panel) that is absent
in DKO EC (bottom panel). Left panel shows the phase contrast images and the right panel GFP images. Bars=80 mm.
doi:10.1371/journal.pone.0008283.g004
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The combination of in vivo and in vitro approaches presented
here reveal an EC autonomous, redundant role for ERK1/2 in
embryonic angiogenesis. The combined results demonstrated that
Erk1/2 regulate both proliferation and migration of EC, two
biological processes that are critical for angiogenesis. Surprisingly,
cell apoptosis was not affected by ablation of Erk1/2 in EC as
Figure 5. ERK1/2 deficient EC show altered actin organization and reduced expression of Paxillin and FAK in vitro. (A) Representative
micrographs of phalloidin stained control (top) and DKO (bottom) aortic EC (n=3). Red=Actin and Green=lentivirus infected cells. The bar graph
represents % EC showing the presence of intra-cellular stress fibers. Bars=20 mm. (B) Representative micrographs of Paxillin-pFAK membrane co-
localization on FN-coated dishes in Erk1
2/2;Erk2
fl/fl (top) and Erk1
2/2;Erk2
fl/fl+Cre (bottom) aortic EC (n=3). Red-Paxillin and Green-pY397 FAK. Boxed
areas are enlarged to show membrane staining in EC. Graphic panel represents % EC showing Paxillin-pY397 FAK co-localization. Bars=20 mm. (C)
Western blot with indicated antibodies of lentivirus infected aortic EC. Erk1
+/2;Erk2
fl/fl (lane 1) and Erk1
2/2;Erk2
fl/fl without (lane 2) and with (lane 3) Cre.
doi:10.1371/journal.pone.0008283.g005
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this discrepancy might be that in the previous in vitro studies
upstream components of the RAS/ERK pathway were targeted,
in particular RAF and MEK [2,17,20]. Thus, the actual role of
ERK1/2 in apoptosis was inferred but not directly tested in these
studies. This raises the possibility that targets of RAF and MEK
other than ERK1/2 may be involved in the observed affects of the
pathway on EC survival.
EC-specific deletion of Erk2 in the Erk1
2/2 background resulted
in embryonic lethality at E9.5-E10.5 and the viable EC-DKO
E9.5 embryos were smaller than the control littermates. We
speculate that the smaller size of EC-DKO embryos is due to Tie2-
Cre mediated deletion of Erk2 starting at E7.5 in the yolk sac EC,
and at E8.5 in the embryonic aorta and common atrial chamber
[31]. In addition, reduced blood vessel development in the embryo
proper likely contributes to the smaller size and in combination
with defective heart development results in lethality of the EC-
DKO mutant embryos.
One mechanism underlying ERK1/2 function in EC involves
regulation of the expression of FAK and Paxillin. ERK1/2 have
been most frequently placed downstream of Src-FAK signaling in
several studies [46,47], but our results demonstrate that ERK1/2
can also act upstream to regulate FAK and Paxillin expression.
One hypothesis to account for this result is that ERK activation by
tyrosine kinases is required for efficient expression of FAK and
Paxillin, which in turn leads to amplification of ERK signaling
when integrin/adhesion pathways are engaged. An alternate
mechanism by which ERK can function upstream of these
Figure 6. ERK1/2 deficient EC show reduced expression of Paxillin and FAK in vivo. (A) Representative cryosections of E9.5 Erk1
2/2;Erk2
fl/fl
control (left) and Erk1
2/2;Erk2
fl/fl ;Tie2-Cre (EC-DKO, right) embryos (n=4 of each genotype) stained with anti-Paxillin. Graphic panel indicates the ratio
of Paxillin positive area to total EC area in %. (B) Anti-FAK staining of representative cryosections from E9.5 Erk1
2/2;Erk2
fl/fl control (left, n=4) and EC-
DKO mutant (right, n=4) embryo. Graphic panel indicates the ratio of FAK positive area to total EC area in %. Boxed areas are enlarged to show
membrane staining in EC. The red dotted lines indicate the outer lining of the EC layer and the arrowheads point to representative EC. Lower
magnification: Bars=25 mm and Higher magnification: Bars=20 mm.
doi:10.1371/journal.pone.0008283.g006
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phosphorylation of Paxillin at Ser83 enhances formation of
Paxillin/FAK complexes in focal adhesions [48,49]. However,
the drastic reduction in FAK and Paxillin expression in EC lacking
ERK1/2 don’t allow the potential role of this mechanism in EC to
be tested. The precise mechanism by which ERK regulates FAK
and Paxillin remains to be determined, but could involve selective
regulation of translation of these proteins, including potentially
through the regulation of specific microRNAs, or by affected
turnover rates for these proteins.
FAK signaling has been linked to EC proliferation as well as
migration, suggesting that the loss of FAK expression could
account for the major phenotypes observed when ERK1/2 are
ablated in EC [45,50]. However, in two separate studies Tie2-Cre
mediated conditional knockout of Fak resulted in a less severe
phenotype than reported here, with embryonic lethality occurring
at E11.5 or later, and without angiogenic phenotypes at E9.5
when defects are obvious with Erk1/2 deletion [38,51]. In
addition, EC apoptosis was identified as a major phenotype in
both of these previous studies. Thus, other targets of ERK1/2 in
addition to FAK and Paxillin likely account for the overall
phenotype observed.
The microarray analysis suggests that the nuclear function of
ERK1/2 is also critical for their action in EC. For example, a
number of genes involved in cell cycle regulation, in particular
Cyclins, CDKs and c-Myc are among ERK targets that can
account for cell proliferation defects in the double mutant mice.
Similarly, the expression of several extracellular proteases (e.g.,
MMPs) involved in promoting cell motility and angiogenesis were
downregulated while extracellular matrix components that inhibit
angiogenesis (e.g., Thrombospondins 1 and 2) were increased by
the absence of ERK1/2. Therefore, the ability of ERK1/2 to
activate an assortment of transcription factors, either directly by
phosphorylation or indirectly through activation of their expres-
sion, is key to their function in EC.
In summary, these in vitro and in vivo results demonstrate a
redundant role for Erk1 and Erk2 in EC, and indicate that targets
at both the cell membrane and in the nucleus account for the
ability of these kinases to regulate EC functions that are necessary
for embryonic angiogenesis.
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Table S1 EMBRYONIC LETHALITY IN Erk1
2/2; Erk2
fl/fl;
Tie2Cre DOUBLE MUTANT MICE
Found at: doi:10.1371/journal.pone.0008283.s001 (0.05 MB
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Table S2 EMBRYONIC LETHALITY IN Erk1
2/2; Erk2
fl/fl;
Tie2Cre DOUBLE MUTANT MICE
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Table S3 MICROARRAY EXPERIMENTAL DESIGN
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Table S4 LIST OF GENES DIFFERENTIALLY EX-
PRESSED (4 FOLD OR GREATER) IN DKO EC BY
MICROARRAY ANALYSIS
Found at: doi:10.1371/journal.pone.0008283.s004 (0.32 MB
DOC)
Table S5 LIST OF GENES DIFFERENTIALLY EX-
PRESSED IN DKO AORTIC AND LUNG EC BY CON-
FIRMED BY qPCR ANALYSIS
Found at: doi:10.1371/journal.pone.0008283.s005 (0.07 MB
DOC)
Figure S1 (A) Schematic illustration of the breeding strategies to
obtain Erk1
2/2;Erk2
fl/fl;Tie2-Cre mutant embryos. Solid triangles
represent the loxP sites. (B) Bar graph indicating the number of
somites in E9.5 embryos with 3 (grey), 2(white), 1(hatched) and 0
(black) copies of Erk. (C) Graphic panel indicates the ratio of ERK
positive to total non-EC, expressed as percent positive non-EC
types such as smooth muscle cells, epithelial cells, cardiomyocytes
etc. (D) Freshly dissected yolk sac from E9.5 embryos (top) and
micrographs of anti-CD31 stained yolk sacs (bottom) from control
(left panel) and Erk1
2/2;Erk2
fl/fl;Tie2-Cre (EC-DKO) mutant (right
panel) embryos. Top panel: Bars=0.25 mm and Bottom panel:
Bars=50mm. (E) Representative paraffin sections from E9.5
control (left, n=3) and EC-DKO (right, n=3) embryo sections
stained with nuclear fast red. The arrowheads indicate the
cellularity of heart. Bars=20 mm. (F) Head regions from E9.5
embryos analyzed by whole mount staining with anti-CD31
antibody. Controls are in the top row and EC-DKO mutants in
the bottom row. Arrowheads highlight examples of blood vessel
staining and branching in the controls that are reduced in the EC-
DKO embryos.
Found at: doi:10.1371/journal.pone.0008283.s006 (3.45 MB TIF)
Figure S2 (A) Typical high speed FACS analysis for cells isolated
from Erk1
2/2;Erk2
fl/fl mice using PE-labeled Di-I-Ac-LDL. Pink
curve (M1) shows FACS for the PE-negative population. Purple
curve (M2) shows FACS for the PE-positive EC population. The
blue curve shows the M2 population that was sorted and collected,
and then reanalyzed by FACS. (B) PECAM (green) and DAPI
(blue) staining of aortic EC. The third figure in the panel is the
merged imaged as indicated. Bars=20 mm. (C) Anti-ERK1/2
staining on cultured aortic EC of the indicated genotype, without
(top panel) and with (bottom panel) Cre. Red-ERK1/2 and Blue-
DaPI. Bars=20 mm. (D) Western blot analysis on lysates from
Erk1
+/2;Erk2
fl/fl-Cre (lane 1), Erk1
2/2;Erk2
fl/fl-Cre (lane 2) and
Erk1
2/2;Erk2
fl/fl+Cre lung EC for ERK1/2. (E) Gene expression
analysis of transcription regulators by q-PCR in aortic EC with
and without ERK1/2. (F) Putative target gene expression analysis
aortic EC with and without ERK1/2. Note that the expression of
these genes was not affected by Erk1/2 status. (G) Gene expression
analysis of cell cycle/proliferation, transcription and cell migra-
tion/ECM remodeling/angiogenesis regulators downregulated
(left panel) and upregulated (right panel) by qPCR in cultured
lung EC with and without ERK1/2. ND-not detected.
Found at: doi:10.1371/journal.pone.0008283.s007 (25.27 MB
TIF)
Figure S3 (A) Graphic panel indicating the ratio of BrDU
positive to total non-EC types such as smooth muscle cells,
epithelial cells, cardiomyocytes etc., expressed as percent positive
non-EC. (B) Anti-BrDU staining on cultured lung EC of the
indicated genotype, without (top panel) and with (bottom panel)
Cre. Red-BrDU and Blue-DaPI. Bars=20 mm. The graph shows
the quantification of the staining data represented as % BrDU
positive EC. (C) Anti-BrDU staining on cultured aortic EC of the
indicated genotype, without (top panel, 3 Erk copies) and with
(bottom panel,1 Erk copy) Cre. Red-BrDU and Blue-DaPI.
Bars=20 mm. The graph shows the quantification of the staining
data represented as % BrDU positive EC. (D) Live/Dead staining
of control (top panels) and DKO (bottom panels) aortic EC. GFP-
lentivirus infected cells and Red-EthD1/apoptotic cells. Graph at
right is quantification of the results. Bars=40 mm. (E) Senescence
associated b-gal staining on control (top) and mutant (bottom)
aortic EC before (left panels) and after (right panels) UV induction.
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results represented as % b-gal positive EC.
Found at: doi:10.1371/journal.pone.0008283.s008 (4.52 MB TIF)
Figure S4 (A) Confluent monolayer of control (top panel) and
DKO (bottom panel) lung EC were wounded and wound closure
was monitored over 24 hrs. Representative results from t=0 h
(left panel) and t=24 h (right panel) are shown. Graph on the
right illustrates the quantification of the number of cells migrating
into the wound over the indicated time points. Bars=40 mm. (B)
Confluent monolayer of aortic EC of the indicated genotype,
without (top panel, 3 Erk copies) and with (bottom panel,1 Erk
copy) Cre were wounded and wound closure was monitored over
24 hrs. Representative results from t=0 h (left panel) and t=24 h
(right panel) are shown. Graph on the right illustrates the
quantification of the number of cells migrating into the wound
over the indicated time points. Bars=40 mm. (C) Migration track
assay on control (left) and a mixed population of DKO (right)
aortic EC. The GFP expressing cells in the right panel are the
mutant EC lacking both Erk1/2 and the non-GFP cells are the
uninfected population of control EC. Graphic panel indicates the
quantification of the non-fluorescent tracks represented as average
area migrated per cell in %.
Found at: doi:10.1371/journal.pone.0008283.s009 (1.93 MB TIF)
Figure S5 (A) Immunofluorescence micrographs of actin
staining in control (top) and DKO (bottom) lung EC by phalloidin
staining. Red-Actin and Green-lentivirus infected EC.
Bars=20 mm. (B) Gene expression analysis of Paxillin and Fak by
q-PCR in aortic EC of the indicated genotype. (C) Western blot
analysis on lysates from Erk1
+/2;Erk2
fl/fl-Cre (lane 1), Erk1
2/2;
Erk2
fl/fl-Cre (lane 2) and Erk1
2/2;Erk2
fl/fl+Cre lung EC for pS473-
AKT. (D) Graphic panels indicate the ratio of Paxillin (left) and
FAK (right) positive to total non-EC (such as smooth muscle cells,
epithelial cells, cardiomyocytes etc) area respectively in %.
Found at: doi:10.1371/journal.pone.0008283.s010 (1.39 MB TIF)
Movie S1 Wound Healing Assay on Erk1/2 Wild type
endothelial cells.
Found at: doi:10.1371/journal.pone.0008283.s011 (14.07 MB
AVI)
Movie S2 Wound Healing Assay on Erk1/2 DKO endothelial
cells.
Found at: doi:10.1371/journal.pone.0008283.s012 (13.69 MB
AVI)
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